拉坦前列素|T2528

2篇文獻(xiàn)

價(jià)格	￥319	￥453	￥788
包裝	1mg	2mg	5mg

最小起訂量	1mg
發(fā)貨地	上海
更新日期	2026-05-08

QQ交談微信洽談

產(chǎn)品詳情

中文名稱:拉坦前列素	英文名稱:Latanoprost
CAS:130209-82-4	品牌: TargetMol
產(chǎn)地: 美國(guó)	保存條件: Keep away from moisture,Store at low temperature Pure form: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
純度規(guī)格: 99.89%	產(chǎn)品類別: 抑制劑
貨號(hào): T001\|T2528

Product Introduction

Bioactivity

名稱	Latanoprost
描述	Latanoprost (Xalatan) is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.
細(xì)胞實(shí)驗(yàn)	HCS cells were inoculated into a 24-well culture plate (Nunc) and cultured in 10% FBS-DMEM/F12 medium at 37°C in a humidified 5% CO2 incubator. After the cells grew into logarithmic phase, the culture medium of each culture plate well was replaced entirely with the medium containing latanoprost at concentrations varying from 50 mg/l to 0.78125 mg/l, respectively. The cells were cultured under the same condition as described earlier, and their morphology and growth status were monitored every 4 h under an Eclipse TS100 inverted microscope.(Only for Reference)
體外活性	Latanoprost functioned as both an indirect activator of AMP-activated protein kinase and a selective retinoid X receptor α (RXRα) antagonist able to selectively antagonise the transcription of a RXRα/peroxisome proliferator-activated receptor γ heterodimer[2]. Latanoprost induced morphological abnormality and viability decline of HCS cells in vitro. It induces cell cycle arrest of HCS cells. Latanoprost induces abnormal changes of plasma membrane, DNA fragmentation and ultrastructural abnormality of HCS cells. Caspase activation in HCS cells is also activated by Latanoprost treatment. Latanoprost induces MTP disruption and quantitative changes of mitochondrion-associated pro-apoptotic regulators in HCS cells[1]. Latanoprost is effective in inhibiting adipogenesis, reducing lipogenesis, promoting fatty acid oxidation and enhancing GLUT4 translocation and glucose uptake both in adipocytes and myotubes[2].
體內(nèi)活性	Latanoprost, a clinical drug for treating primary open-angle glaucoma and intraocular hypertension, effectively ameliorates glucose and lipid disorders in two mouse models of type 2 diabetes. Its treatment improves glucose tolerance. Chronic administration of latanoprost decreases serum lipids and enhances insulin signalling in white adipose tissue and skeletal muscle. It effectually activates AMPK and regulates glucose and lipid metabolism-relevant genes in diabetic mice[2].
存儲(chǔ)條件	Keep away from moisture,Store at low temperature Pure form: -20°C for 3 years \| In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
溶解度	H2O : 125 mg/mL (288.96 mM) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 1 mg/mL (2.31 mM), Sonication is recommended. DMSO : 4.33 mg/mL (10.01 mM), Sonication is recommended.
關(guān)鍵字	RXR \| retinoid X receptor α \| RAR \| prostanoid selective FP receptor \| ProstaglandinReceptor \| Prostaglandin Receptor \| PHXA-41 \| PHXA 41 \| Latanoprost \| Inhibitor \| inhibit
相關(guān)產(chǎn)品	Rutin \| Benzyl nicotinate \| Lornoxicam \| p-Hydroxycinnamic acid \| Rebamipide \| Tranilast \| Azathioprine \| Kynurenic acid \| Monomethyl fumarate \| Ozagrel \| Pamoic acid disodium \| Pranoprofen
相關(guān)庫	經(jīng)典已知活性庫 \| 抗癌上市藥物庫 \| 已知活性化合物庫 \| 抗衰老化合物庫 \| FDA 上市藥物庫 \| GPCR靶點(diǎn)分子庫 \| 免疫/炎癥分子化合物庫 \| 膜蛋白靶向化合物庫 \| 疼痛相關(guān)化合物庫 \| 藥物功能重定位化合物庫 \| 抗癌臨床化合物庫 \| 神經(jīng)元分化化合物庫

關(guān)鍵字：拉坦前列腺素;拉坦前列素;Xalatan;PHXA41;TargetMol

公司簡(jiǎn)介

上海陶術(shù)生物科技有限公司為美國(guó)Target Molecule Corp. ( Target Mol ) 在上海建立的全資子公司。我們與美國(guó)波士頓、德國(guó)慕尼黑的同事一起，為北美、歐洲和亞洲從事藥物研發(fā)和生物學(xué)研究的科學(xué)家提供優(yōu)質(zhì)的產(chǎn)品和專業(yè)的服務(wù)。公司下設(shè)篩選事業(yè)部，化學(xué)事業(yè)部，生物事業(yè)部和新材料部。從虛擬篩選到實(shí)體化合物分子供應(yīng)；從商業(yè)化產(chǎn)品銷售到個(gè)性化定制合成；從對(duì)明確靶點(diǎn)的分子篩選到對(duì)明確分子的多靶點(diǎn)篩選，從高通量篩選到化學(xué)結(jié)構(gòu)優(yōu)化，我們都可以滿足您的科研用品及技術(shù)服務(wù)的需求。經(jīng)過在中國(guó)市場(chǎng)五年的精心耕耘，我們已成為篩選化合物領(lǐng)域優(yōu)秀的供應(yīng)商，為超過五百家學(xué)校和各類企業(yè)提供了品質(zhì)卓越的小分子化合物和藥物篩

成立日期	2013-04-18 （14年）	注冊(cè)資本	566.2651萬人民幣
員工人數(shù)	100-500人	年?duì)I業(yè)額	￥ 1億以上
主營(yíng)行業(yè)	化學(xué)試劑,生物活性小分子	經(jīng)營(yíng)模式	貿(mào)易,試劑,定制,服務(wù)

TargetMol中國(guó)（陶術(shù)生物）

VIP 14年

公司成立：14年
注冊(cè)資本：566.2651萬人民幣
企業(yè)類型：有限責(zé)任公司(自然人投資或控股)
主營(yíng)產(chǎn)品：小分子抑制劑，藥物篩選化合物庫，天然產(chǎn)物，活性分子化合物等
公司地址：上海市閘北區(qū)江場(chǎng)三路28號(hào)4樓

進(jìn)入店鋪

詢盤

店內(nèi)推薦

上海陶素獨(dú)家代理chemdiv成藥庫

￥100000

雷帕霉素

￥286.00

雷帕霉素

￥396